KURA — KURA ONCOLOGY INC

Ownership history in Rangeley Capital, LLC  ·  3 quarters on record

This page tracks every 13F SEC filing in which Rangeley Capital, LLC reported a position in KURA ONCOLOGY INC (KURA). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.92% (2025 Q3)
Avg. % of fund
0.87%
First filed
2025 Q2
Last filed
2025 Q4
Quarters held
3
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 REDUCED 102,900 -17,100 -14.2% 0.89% $1.1M $10.39
2025 Q3 ADDED 120,000 +4,000 +3.4% 0.92% $1.1M $8.85
2025 Q2 INITIATED 116,000 — — 0.80% $669K $5.77
% of Fund (quarterly)    KURA price (monthly, adj. close)

Other funds also holding KURA

As of 2025 Q4 — sorted by position size

ALETHEA CAPITAL MANAGEMENT, LLC 3Y 7Y 7.18% Prosight Management, LP 3Y 7Y 5.43% BVF INC/IL 3Y 7Y 3.01% Lion Point Capital, LP 3Y 7Y 2.47% SUVRETTA CAPITAL MANAGEMENT, LLC 3Y 7Y 1.83% 1492 Capital Management LLC 3Y 7Y 1.8% SECTOR GAMMA AS 3Y 7Y 1.08% Rhenman & Partners Asset Management AB 3Y 7Y 0.85% NAN FUNG TRINITY (HK) Ltd 3Y 0.79% ARMISTICE CAPITAL, LLC 3Y 7Y 0.61%
← Back to Rangeley Capital, LLC Holdings